Last reviewed · How we verify
NCT05517187: PRF
Efficacy of Regenerative Endodontic Treatment With PRF as a Secondary Treatment of Mature Necrotic Incisors in Adolescents
NA trial testing no intervention in Dental Pulp Necroses in 40 participants. Status unknown.
1 March 2023
Quick facts
| Lead sponsor | Nahda University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 10 March 2022 |
| Primary completion | 1 March 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- no intervention
- Platelet rich fibrin — full drug profile →
Conditions studied
- Dental Pulp Necroses — all drugs for Dental Pulp Necroses →
Sponsor
Nahda University
Who can join
Adults 11 to 18, any sex, with Dental Pulp Necroses. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evalaution of clinical success of secondary treatment for total 40 permanent incisors with failed root canal treatment with apical radiolucency. Twenty of of these permanent incisors will be treated with regenerative endodontic treatment(RET) with platelets rich fibrin PRF as intervention group vs. 20 incisors control group secondary treated with (RET) with induced blood clot (BC).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Change in the size of apical radiolucencies in adolescent's mature maxillary incisors following retreatment with two regenerative endodontic techniques: a 12-month randomised clinical trial using volume-based cone-beam computed tomography.
Wahba NKO, Bahnasy SSEL, ElMakawi YM, Dummer PMH, et al · · 2025 · cited 2× · PMID 40319119 · DOI 10.1007/s00784-025-06344-y -
Postoperative pain after pulpotomy versus pulpectomy of primary molars with symptomatic irreversible pulpitis: an equivalent randomized clinical trial.
Sermani DI, Abdelmotelb MA, Elheeny AAH. · · 2026 · PMID 42035058 · DOI 10.1186/s12903-026-08329-z
Verify or expand the search:
- PubMed search for NCT05517187
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of no intervention
Trials testing the same drug.
- NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
- NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
- NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
- NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
- NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting
Other Nahda University trials
Trials by the same sponsor.
- NCT07086235 — Remineralization Capacity and Patient Satisfaction of Self-Assembling Peptide With Fluoride Versus Tooth Protective Coat · NA · completed
- NCT05623605 — Evaluation of New Different Herbal Mouthwashes Against Caries Forming Bacteria, RCT · Phase 4 · unknown
- NCT05657132 — Antibacterial Effect of New Herbal Paste Used as an Intracanal Medication · Phase 3 · unknown
- NCT05861297 — Immune Thrombocytopenia Management in Adults · Phase 4 · unknown
- NCT04073901 — Comparative Study Between Zirconia Crowns and Endocrowns in Pulpotomized Primary Molars · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05517187 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nahda University
- Last refreshed: 31 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05517187.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing